Skip to main content

Table 2 Sociodemographic and medical characteristics of study participants by group

From: The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

Variables Antipsychotics group (n = 112) Control group (n = 114)
Age (mean ± SD) 35.73 ± 10.28 35.73 ± 8.16
Gender n (%)
 Male
 Female
73 (65.2%)
39 (34.8%)
69 (60.5%)
45 (39.5%)
Ethnicity n (%)
 Qataris and Arabs
 Non-Arabs
79 (71.2%)*
32 (28.8%)
52 (45.6%)
62 (54.4%)**
Marital status n (%)
 Married
 Single
 Divorced
43 (38.4%)
57 (50.9%)*
12 (10.7%)*
83 (72.8%)**
30 (26.3%)
1 (0.9%)
Degree n (%)
 None
 School
 Vocational
 College/graduate
4 (3.6%)
72 (64.3%)*
7 (6.3%)
28 (25.0%)
4 (3.5%)
45 (39.5%)
15 (13.2%)
49 (43.0%)**
Employment n (%)
 Employed
 Not employed
 Other (student, retired, etc.)
41 (36.6%)
62 (55.4%)*
9 (8%)
103 (90.4%)**
9 (7.8%)
2 (1.8%)
Smoking/current n (%)
 Yes
 No
40 (36.7%)*
69 (63.3%)
18 (18%)
82 (82%)**
Smoking/ever n (%)
 Yes
 No
52 (47.3%)*
58 (52.7%)
26 (22.8%)
88 (77.2%)**
History of Diabetes n (%)
 Yes
 No
9 (8.2%)
101 (91.8%)
8 (7.3%)
101 (92.7%)
Family history of diabetes n (%)
 Yes
 No
74 (66.1%)
38 (33.9%)
74 (64.9%)
40 (35.1%)
Body mass index (BMI)
(mean ± SD)
29.12 ± 6.95 27.74 ± 5.05
  1. *Higher than the control group; **Higher than the antipsychotics group (p < 0.05)